Cervical cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) No edit summary |
Nima Nasiri (talk | contribs) |
||
Line 26: | Line 26: | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan=" | | colspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
! colspan=" | ! colspan="12" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
Line 38: | Line 38: | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abnormal vaginal bleeding | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abnormal vaginal bleeding | ||
!Heavy menstrual bleeding | |||
!Postcoital bleeding | |||
!Premenopausal bleeding | |||
!Postmenopausal bleeding | |||
!Intermenstrual bleeding | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abnormal vaginal dyscharge | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abnormal vaginal dyscharge | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pelvic pain or pressure | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pelvic pain or pressure | ||
Line 56: | Line 61: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical cancer | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical cancer | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 77: | Line 87: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical polyp | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical polyp | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 103: | Line 118: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical leiomyoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical leiomyoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 124: | Line 144: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical lymphoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical lymphoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 145: | Line 170: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical sarcoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical sarcoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 166: | Line 196: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical erosion(Ectropion) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical erosion(Ectropion) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 187: | Line 222: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervicitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervicitis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 208: | Line 248: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |IUD use | | style="background: #DCDCDC; padding: 5px; text-align: center;" |IUD use | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 228: | Line 273: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pelvic inflammatory diseases | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Pelvic inflammatory diseases | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 248: | Line 298: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endometriosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Endometriosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 268: | Line 323: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adnemyosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Adnemyosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 288: | Line 348: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Postcoital bleeding | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Postcoital bleeding | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 308: | Line 373: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |DES exposure (Clear cell adenocarcinoma) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |DES exposure (Clear cell adenocarcinoma) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 327: | Line 397: | ||
|- | |- | ||
|Paget's disease of vulva | |Paget's disease of vulva | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 347: | Line 422: | ||
|- | |- | ||
|Vaginal cancer | |Vaginal cancer | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | | | ||
| | | |
Revision as of 19:03, 24 January 2019
Cervical cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cervical cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Cervical cancer differential diagnosis |
Risk calculators and risk factors for Cervical cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Cervical cancer must be differentiated from other diseases that cause abnormal vaginal bleeding, such as cervical polyp, cervical leiomyoma, invasion of the cervix from primary uterine malignancy, vaginal cancer, cervical lymphoma, metastases to cervix, and cervical ectopic pregnancy.
Cervical cancer differential diagnosis
- Cervical cancer must be differentiated from a mass involving the cervix, and causing abnormal vaginal bleeding:
- Cervical polyp
- Cervical leiomyoma
- Cervical lymphoma
- Cervical sarcoma
- Metastases to the cervix
- Cervical ectopic pregnancy
- Cervical polyp
- Cervicitis
- Cervical erosion ( Ectropion )
- IUD use
- Pelvic inflammatory disease
- Endometriosis
- Adenomyosis
- Postcoital bleeding
- Clear cell adenocarcinoma
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical exam | Lab Findings | Imaging | Histopathology | |||||||||||||||||||||||||
Abnormal vaginal bleeding | Heavy menstrual bleeding | Postcoital bleeding | Premenopausal bleeding | Postmenopausal bleeding | Intermenstrual bleeding | Abnormal vaginal dyscharge | Pelvic pain or pressure | Itching or burning of the vulva | Abdominal pain | Weight loss | Vaginal/vulvar sores or change in color | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | |||||||||
Cervical cancer | |||||||||||||||||||||||||||||
Cervical polyp | |||||||||||||||||||||||||||||
Cervical leiomyoma | |||||||||||||||||||||||||||||
Cervical lymphoma | |||||||||||||||||||||||||||||
Cervical sarcoma | |||||||||||||||||||||||||||||
Cervical erosion(Ectropion) | |||||||||||||||||||||||||||||
Cervicitis | |||||||||||||||||||||||||||||
IUD use | |||||||||||||||||||||||||||||
Pelvic inflammatory diseases | |||||||||||||||||||||||||||||
Endometriosis | |||||||||||||||||||||||||||||
Adnemyosis | |||||||||||||||||||||||||||||
Postcoital bleeding | |||||||||||||||||||||||||||||
DES exposure (Clear cell adenocarcinoma) | |||||||||||||||||||||||||||||
Paget's disease of vulva | |||||||||||||||||||||||||||||
Vaginal cancer |